Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,929 GBX | -2.23% | -3.55% | +7.94% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
Financials (USD)
Sales 2024 * | 2.99B | Sales 2025 * | 3.09B | Capitalization | 5.56B |
---|---|---|---|---|---|
Net income 2024 * | 414M | Net income 2025 * | 451M | EV / Sales 2024 * | 2.15 x |
Net Debt 2024 * | 852M | Net Debt 2025 * | 607M | EV / Sales 2025 * | 2 x |
P/E ratio 2024 * |
13.7
x | P/E ratio 2025 * |
12.5
x | Employees | 9,100 |
Yield 2024 * |
2.84% | Yield 2025 * |
3.01% | Free-Float | 65.59% |
Latest transcript on Hikma Pharmaceuticals PLC
1 day | -0.41% | ||
1 week | -1.80% | ||
Current month | +2.18% | ||
1 month | +8.14% | ||
3 months | -1.58% | ||
6 months | +11.86% | ||
Current year | +9.89% |
Managers | Title | Age | Since |
---|---|---|---|
Riad Mishlawi
CEO | Chief Executive Officer | 60 | 89-12-31 |
Khalid Nabilsi
DFI | Director of Finance/CFO | 52 | 00-12-31 |
Said Darwazah
CHM | Chairman | 67 | 80-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Hurt
BRD | Director/Board Member | 66 | 20-04-30 |
Nina Henderson
BRD | Director/Board Member | 72 | 16-09-30 |
Victoria Hull
BRD | Director/Board Member | 62 | 22-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 1,083 M€ | +4.70% | ||
0.25% | 3 M€ | +9.95% | - | |
0.20% | 11 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1,931 | -2.13% | 63 723 |
24-05-20 | 1,973 | -0.25% | 116,701 |
24-05-17 | 1,978 | -0.25% | 219,724 |
24-05-16 | 1,983 | -2.22% | 233,264 |
24-05-15 | 2,028 | +1.30% | 238,648 |
Delayed Quote London S.E., May 21, 2024 at 03:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.89% | 5.56B | |
+34.35% | 705B | |
+30.91% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.11% | 238B | |
-3.19% | 210B | |
+10.38% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- HIK Stock